Detalhe da pesquisa
1.
Real-world applications of PARPi maintenance therapy for recurrent ovarian cancer: A single-center study in China.
Gynecol Oncol
; 170: 25-31, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36608384
2.
Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
Cancer Lett
; 295(1): 38-43, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20207071